We would like to thank our exhibitors for sponsoring this meeting, which includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Tuesday, May 12, 2026
9:20 AM - 10:15 AM
Chair’s opening remarks followed by: Pulmonary hypertension: Early recognition and specialist referral pathways
  • Identifying red flags in general respiratory clinics
  • Managing complex comorbidities and treatment escalation
10:25 AM - 11:10 AM
Severe Asthma: Right patient, right place
  • What is severe asthma? 
  • Best practice for referring severe asthma patients 
  • Real world case study examples 

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only. 

11:20 AM - 12:05 PM
Transforming COPD care. Connected care: collaborative strategies for transforming COPD management
  • COPD burden and the risk of premature mortality 
  • Exacerbations as the driving force of poor outcomes in COPD 
  • Development of a COPD E-Bundle to support clinical consistency and quality of care 

This is a promotional symposium sponsored and organised by AstraZeneca and is intended for UK HCPs only. 

12:15 PM - 1:00 PM
Advanced lung cancer pathways: Delivering precision medicine at scale
  • Embedding molecular diagnostics into rapid diagnostic pathways
  • Coordinating thoracic surgery, oncology, radiology, and respiratory teams
  • Managing toxicity, frailty, and survivorship within the MDT
1:10 PM - 1:55 PM
Cystic fibrosis in the era of CFTR modulators: New challenges for adult services
  • Long-term monitoring and managing residual disease burden 
  • Transitioning from paediatric to adult specialist care 
  • Addressing mental health, fertility, and metabolic complications 
2:05 PM - 2:50 PM
The changing face of Tuberculosis: From reactivation to MDR-TB
  • UK epidemiology, including resurgence in certain populations
  • Diagnostic pathways: from latent to active TB
  • Management challenges: drug resistance, adherence, and public health considerations
3:00 PM - 3:45 PM
Sleep-disordered breathing beyond simple OSA: Managing complex ventilatory failure
  • Identifying obesity hypoventilation and neuromuscular disease in respiratory clinics
  • Setting up home ventilation pathways that reduce admissions
  • Monitoring adherence and long-term outcomes using digital tools

4 CPD hours

SPEAKERS